 |
Interleukin-1 alpha, human recombinant |
|---|---|
| Trade Name | |
| Orphan Indication | For the promotion of early engraftment in bone marrow transplantation |
| USA Market Approval | USA |
| USA Designation Date | 1991-06-17 00:00:00 |
| Sponsor | Immunex Corporation;51 University Street;Seattle, Washington, 98101 |
